Simplify Logo

Full-Time

Associate Manager

Rcm

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Mid

Chicago, IL, USA

This is a hybrid position requiring onsite presence.

Category
Procurement & Sourcing
Operations & Logistics
Required Skills
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor's degree in business, healthcare administration, biology and/or genetics-related fields
  • 3+ years of experience in healthcare consulting, revenue cycle management, healthcare operations, or related fields.
  • Familiarity with healthcare reimbursement, payer policies, and regulatory compliance in revenue cycle is a plus.
  • Experience in Microsoft Excel and other data analysis tools.
Responsibilities
  • Manage a team of RCM Specialists focused on patient insurance verification, missing billing workflows, and clinical document review.
  • Monitor and own Internal Billing Operations worklists using reporting and dashboarding tools.
  • Establish and monitor Key Performance Indicators (KPIs) to track and improve the efficiency and effectiveness of the pre-billing operations.
  • Develop Standard Operating Procedures (SOPs) for key Internal Billing Operations workflows.
  • Implement and manage new systems and processes to improve operational efficiency and quality.
  • Lead initiatives to identify root causes of incorrect claim submissions and implement proactive measures to increase payment rates.
  • Collaborate with cross-functional teams to enhance upstream processes and technologies.
  • Handle ad hoc requests and special projects as needed, demonstrating flexibility and adaptability to meet evolving business needs.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

4%

1 year growth

13%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.

Help us improve and share your feedback! Did you find this helpful?